Asymptomatic tuberculosis: undetected and underestimated, but not unimportant
- PMID: 40127658
- DOI: 10.1016/S0140-6736(25)00555-0
Asymptomatic tuberculosis: undetected and underestimated, but not unimportant
Conflict of interest statement
KD is a principal investigator for the XACT-3 and XACT-19 trials (RIA2018D-2505 and RIA2020S-3295) for ACF for tuberculosis and is supported by the UK Medical Research Council, the Wellcome Trust, EU Horizon 2020 (EDCTP2), and the South African Medical Research Council. TP is a sub-investigator for the XACT-3 trial, which is funded by the EDCTP (RIA2018D-2505). GJF is a principal investigator for the FLIRT trial for isoniazid-resistant tuberculosis, and a sub-investigator for the ACT5 trial, both funded by the Australian National Health and Medical Research Council; is a member of the data safety monitoring board for the DRAMATIC trial (Boston University); and is a Director of the non-profit Australian Respiratory Council supporting clinical care and research for tuberculosis in Australia and the Asia Pacific region.
LinkOut - more resources
Full Text Sources